Robert D. Budens

Array ( [id] => 3985192 [patent_doc_number] => 05861490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Suppressor of HIV replication and transcription' [patent_app_type] => 1 [patent_app_number] => 8/471430 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 12237 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861490.pdf [firstpage_image] =>[orig_patent_app_number] => 471430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3615318 [patent_doc_number] => 05534621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-09 [patent_title] => 'Immunoaffinity purification methods using single polypeptide chain binding molecules' [patent_app_type] => 1 [patent_app_number] => 8/468992 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 72 [patent_no_of_words] => 23532 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/534/05534621.pdf [firstpage_image] =>[orig_patent_app_number] => 468992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3708134 [patent_doc_number] => 05654407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Human anti-TNF antibodies' [patent_app_type] => 1 [patent_app_number] => 8/435246 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 30 [patent_no_of_words] => 11691 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654407.pdf [firstpage_image] =>[orig_patent_app_number] => 435246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763014 [patent_doc_number] => 05772998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Monoclonal antibodies to transforming growth factor-beta and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/434976 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6450 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/772/05772998.pdf [firstpage_image] =>[orig_patent_app_number] => 434976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3821429 [patent_doc_number] => 05783185 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Monoclonal antibodies to transforming growth factor-beta and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/434977 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6438 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783185.pdf [firstpage_image] =>[orig_patent_app_number] => 434977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4283751 [patent_doc_number] => 06210874 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Synthetic peptides and mixtures thereof for detecting HIV antibodies' [patent_app_type] => 1 [patent_app_number] => 8/432520 [patent_app_country] => US [patent_app_date] => 1995-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8301 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/210/06210874.pdf [firstpage_image] =>[orig_patent_app_number] => 432520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328131 [patent_doc_number] => 06312939 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Genetically engineered glutaminase and its use in antiviral and anticancer therapy' [patent_app_type] => 1 [patent_app_number] => 8/050482 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 10230 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312939.pdf [firstpage_image] =>[orig_patent_app_number] => 050482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690686 [patent_doc_number] => 05691447 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies' [patent_app_type] => 1 [patent_app_number] => 8/410360 [patent_app_country] => US [patent_app_date] => 1995-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11601 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691447.pdf [firstpage_image] =>[orig_patent_app_number] => 410360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619162 [patent_doc_number] => 05688655 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Method of screening for protein inhibitors and activators' [patent_app_type] => 1 [patent_app_number] => 8/408443 [patent_app_country] => US [patent_app_date] => 1995-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 15681 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688655.pdf [firstpage_image] =>[orig_patent_app_number] => 408443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4050404 [patent_doc_number] => 05869620 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Multivalent antigen-binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/392338 [patent_app_country] => US [patent_app_date] => 1995-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 41 [patent_no_of_words] => 16193 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869620.pdf [firstpage_image] =>[orig_patent_app_number] => 392338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689533 [patent_doc_number] => 05679356 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Use of GM-CSF as a vaccine adjuvant' [patent_app_type] => 1 [patent_app_number] => 8/367114 [patent_app_country] => US [patent_app_date] => 1995-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4948 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679356.pdf [firstpage_image] =>[orig_patent_app_number] => 367114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4042235 [patent_doc_number] => 05968509 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Antibodies with binding affinity for the CD3 antigen' [patent_app_type] => 1 [patent_app_number] => 8/362780 [patent_app_country] => US [patent_app_date] => 1994-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 11132 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968509.pdf [firstpage_image] =>[orig_patent_app_number] => 362780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3722682 [patent_doc_number] => 05681718 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof' [patent_app_type] => 1 [patent_app_number] => 8/358552 [patent_app_country] => US [patent_app_date] => 1994-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5009 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681718.pdf [firstpage_image] =>[orig_patent_app_number] => 358552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3821048 [patent_doc_number] => 05759554 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Immunostimulatory bacterial cell wall traction' [patent_app_type] => 1 [patent_app_number] => 8/352452 [patent_app_country] => US [patent_app_date] => 1994-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5539 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759554.pdf [firstpage_image] =>[orig_patent_app_number] => 352452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656359 [patent_doc_number] => 05658803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Monoclonal antibodies reactive with cachectin' [patent_app_type] => 1 [patent_app_number] => 8/351553 [patent_app_country] => US [patent_app_date] => 1994-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5299 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658803.pdf [firstpage_image] =>[orig_patent_app_number] => 351553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3738617 [patent_doc_number] => 05753503 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Human monoclonal anti-HIV-I-antibodies' [patent_app_type] => 1 [patent_app_number] => 8/347966 [patent_app_country] => US [patent_app_date] => 1994-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 3662 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753503.pdf [firstpage_image] =>[orig_patent_app_number] => 347966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4173851 [patent_doc_number] => 06036956 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Method and dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease' [patent_app_type] => 1 [patent_app_number] => 8/344360 [patent_app_country] => US [patent_app_date] => 1994-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 8001 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/036/06036956.pdf [firstpage_image] =>[orig_patent_app_number] => 344360 [rel_patent_id] =>[rel_patent_doc_number] =>)